nodes	percent_of_prediction	percent_of_DWPC	metapath
Zaleplon—CYP3A7—Tretinoin—peripheral nervous system neoplasm	0.111	0.189	CbGbCtD
Zaleplon—CYP3A7-CYP3A51P—Tretinoin—peripheral nervous system neoplasm	0.111	0.189	CbGbCtD
Zaleplon—CYP3A5—Tretinoin—peripheral nervous system neoplasm	0.083	0.142	CbGbCtD
Zaleplon—CYP3A7—Vincristine—peripheral nervous system neoplasm	0.0508	0.087	CbGbCtD
Zaleplon—CYP3A7-CYP3A51P—Vincristine—peripheral nervous system neoplasm	0.0508	0.087	CbGbCtD
Zaleplon—CYP3A5—Vincristine—peripheral nervous system neoplasm	0.0381	0.0653	CbGbCtD
Zaleplon—CYP3A5—Etoposide—peripheral nervous system neoplasm	0.0349	0.0598	CbGbCtD
Zaleplon—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0348	0.0596	CbGbCtD
Zaleplon—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0324	0.0554	CbGbCtD
Zaleplon—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0149	0.0255	CbGbCtD
Zaleplon—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0136	0.0233	CbGbCtD
Zaleplon—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00929	0.0159	CbGbCtD
Zaleplon—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000182	0.000437	CcSEcCtD
Zaleplon—Migraine—Doxorubicin—peripheral nervous system neoplasm	0.000182	0.000436	CcSEcCtD
Zaleplon—Affect lability—Doxorubicin—peripheral nervous system neoplasm	0.000182	0.000436	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000181	0.000435	CcSEcCtD
Zaleplon—Discomfort—Etoposide—peripheral nervous system neoplasm	0.00018	0.000433	CcSEcCtD
Zaleplon—Breast disorder—Epirubicin—peripheral nervous system neoplasm	0.00018	0.000433	CcSEcCtD
Zaleplon—Aspartate aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.00018	0.000432	CcSEcCtD
Zaleplon—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000178	0.000429	CcSEcCtD
Zaleplon—Face oedema—Doxorubicin—peripheral nervous system neoplasm	0.000178	0.000428	CcSEcCtD
Zaleplon—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000178	0.000428	CcSEcCtD
Zaleplon—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000177	0.000426	CcSEcCtD
Zaleplon—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000177	0.000426	CcSEcCtD
Zaleplon—Nausea—Topotecan—peripheral nervous system neoplasm	0.000177	0.000425	CcSEcCtD
Zaleplon—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000176	0.000424	CcSEcCtD
Zaleplon—Gastritis—Epirubicin—peripheral nervous system neoplasm	0.000176	0.000424	CcSEcCtD
Zaleplon—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000176	0.000424	CcSEcCtD
Zaleplon—Muscular weakness—Epirubicin—peripheral nervous system neoplasm	0.000176	0.000423	CcSEcCtD
Zaleplon—Alanine aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000176	0.000423	CcSEcCtD
Zaleplon—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000175	0.000422	CcSEcCtD
Zaleplon—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000175	0.000422	CcSEcCtD
Zaleplon—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000175	0.00042	CcSEcCtD
Zaleplon—Mood swings—Doxorubicin—peripheral nervous system neoplasm	0.000175	0.00042	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000174	0.000418	CcSEcCtD
Zaleplon—Ataxia—Doxorubicin—peripheral nervous system neoplasm	0.000173	0.000417	CcSEcCtD
Zaleplon—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000173	0.000417	CcSEcCtD
Zaleplon—Nausea—Melphalan—peripheral nervous system neoplasm	0.000173	0.000416	CcSEcCtD
Zaleplon—Asthma—Epirubicin—peripheral nervous system neoplasm	0.000172	0.000414	CcSEcCtD
Zaleplon—Dysphagia—Epirubicin—peripheral nervous system neoplasm	0.000172	0.000414	CcSEcCtD
Zaleplon—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000171	0.000412	CcSEcCtD
Zaleplon—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000171	0.00041	CcSEcCtD
Zaleplon—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.000171	0.00041	CcSEcCtD
Zaleplon—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000171	0.00041	CcSEcCtD
Zaleplon—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000171	0.00041	CcSEcCtD
Zaleplon—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.00017	0.000409	CcSEcCtD
Zaleplon—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.00017	0.000409	CcSEcCtD
Zaleplon—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.00017	0.000408	CcSEcCtD
Zaleplon—Dry skin—Doxorubicin—peripheral nervous system neoplasm	0.000169	0.000406	CcSEcCtD
Zaleplon—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000169	0.000406	CcSEcCtD
Zaleplon—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000168	0.000405	CcSEcCtD
Zaleplon—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.000168	0.000403	CcSEcCtD
Zaleplon—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.000167	0.000401	CcSEcCtD
Zaleplon—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000167	0.000401	CcSEcCtD
Zaleplon—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000166	0.000399	CcSEcCtD
Zaleplon—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000166	0.000399	CcSEcCtD
Zaleplon—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.000166	0.000398	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000165	0.000396	CcSEcCtD
Zaleplon—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000163	0.000393	CcSEcCtD
Zaleplon—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.000163	0.000392	CcSEcCtD
Zaleplon—Pain—Cisplatin—peripheral nervous system neoplasm	0.000163	0.000392	CcSEcCtD
Zaleplon—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000163	0.000391	CcSEcCtD
Zaleplon—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.000163	0.000391	CcSEcCtD
Zaleplon—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.000161	0.000387	CcSEcCtD
Zaleplon—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000161	0.000386	CcSEcCtD
Zaleplon—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.000159	0.000383	CcSEcCtD
Zaleplon—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.000159	0.000383	CcSEcCtD
Zaleplon—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000159	0.000383	CcSEcCtD
Zaleplon—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000158	0.000381	CcSEcCtD
Zaleplon—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000158	0.000379	CcSEcCtD
Zaleplon—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.000157	0.000378	CcSEcCtD
Zaleplon—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000157	0.000378	CcSEcCtD
Zaleplon—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000157	0.000377	CcSEcCtD
Zaleplon—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000157	0.000377	CcSEcCtD
Zaleplon—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000156	0.000375	CcSEcCtD
Zaleplon—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000156	0.000375	CcSEcCtD
Zaleplon—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000155	0.000374	CcSEcCtD
Zaleplon—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000155	0.000374	CcSEcCtD
Zaleplon—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000155	0.000373	CcSEcCtD
Zaleplon—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000155	0.000372	CcSEcCtD
Zaleplon—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.000155	0.000371	CcSEcCtD
Zaleplon—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000153	0.000369	CcSEcCtD
Zaleplon—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000152	0.000366	CcSEcCtD
Zaleplon—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000152	0.000365	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000151	0.000363	CcSEcCtD
Zaleplon—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000151	0.000363	CcSEcCtD
Zaleplon—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000151	0.000362	CcSEcCtD
Zaleplon—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.00015	0.00036	CcSEcCtD
Zaleplon—Constipation—Etoposide—peripheral nervous system neoplasm	0.000149	0.000359	CcSEcCtD
Zaleplon—Pain—Etoposide—peripheral nervous system neoplasm	0.000149	0.000359	CcSEcCtD
Zaleplon—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000149	0.000359	CcSEcCtD
Zaleplon—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000149	0.000358	CcSEcCtD
Zaleplon—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000148	0.000356	CcSEcCtD
Zaleplon—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000147	0.000354	CcSEcCtD
Zaleplon—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000147	0.000354	CcSEcCtD
Zaleplon—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000146	0.000352	CcSEcCtD
Zaleplon—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.00035	CcSEcCtD
Zaleplon—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000145	0.000349	CcSEcCtD
Zaleplon—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000145	0.000349	CcSEcCtD
Zaleplon—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000145	0.000348	CcSEcCtD
Zaleplon—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000144	0.000347	CcSEcCtD
Zaleplon—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000144	0.000346	CcSEcCtD
Zaleplon—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000144	0.000346	CcSEcCtD
Zaleplon—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000143	0.000345	CcSEcCtD
Zaleplon—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.000344	CcSEcCtD
Zaleplon—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000143	0.000344	CcSEcCtD
Zaleplon—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000143	0.000343	CcSEcCtD
Zaleplon—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000141	0.000339	CcSEcCtD
Zaleplon—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000141	0.000339	CcSEcCtD
Zaleplon—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00014	0.000337	CcSEcCtD
Zaleplon—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.000335	CcSEcCtD
Zaleplon—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000139	0.000334	CcSEcCtD
Zaleplon—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.000333	CcSEcCtD
Zaleplon—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000138	0.000332	CcSEcCtD
Zaleplon—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000138	0.000332	CcSEcCtD
Zaleplon—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.000332	CcSEcCtD
Zaleplon—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000137	0.00033	CcSEcCtD
Zaleplon—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000137	0.000329	CcSEcCtD
Zaleplon—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000136	0.000328	CcSEcCtD
Zaleplon—Rash—Vincristine—peripheral nervous system neoplasm	0.000136	0.000327	CcSEcCtD
Zaleplon—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000136	0.000327	CcSEcCtD
Zaleplon—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000327	CcSEcCtD
Zaleplon—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000136	0.000326	CcSEcCtD
Zaleplon—Headache—Vincristine—peripheral nervous system neoplasm	0.000135	0.000325	CcSEcCtD
Zaleplon—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.000323	CcSEcCtD
Zaleplon—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.000322	CcSEcCtD
Zaleplon—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000133	0.00032	CcSEcCtD
Zaleplon—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000133	0.000319	CcSEcCtD
Zaleplon—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000129	0.00031	CcSEcCtD
Zaleplon—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000129	0.000309	CcSEcCtD
Zaleplon—Nausea—Vincristine—peripheral nervous system neoplasm	0.000128	0.000308	CcSEcCtD
Zaleplon—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000127	0.000305	CcSEcCtD
Zaleplon—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000302	CcSEcCtD
Zaleplon—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000125	0.000301	CcSEcCtD
Zaleplon—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000125	0.000299	CcSEcCtD
Zaleplon—Chills—Epirubicin—peripheral nervous system neoplasm	0.000124	0.000297	CcSEcCtD
Zaleplon—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000124	0.000297	CcSEcCtD
Zaleplon—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.000296	CcSEcCtD
Zaleplon—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000122	0.000293	CcSEcCtD
Zaleplon—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000121	0.00029	CcSEcCtD
Zaleplon—Rash—Cisplatin—peripheral nervous system neoplasm	0.00012	0.000289	CcSEcCtD
Zaleplon—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00012	0.000289	CcSEcCtD
Zaleplon—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.00012	0.000289	CcSEcCtD
Zaleplon—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000287	CcSEcCtD
Zaleplon—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000286	CcSEcCtD
Zaleplon—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000118	0.000284	CcSEcCtD
Zaleplon—Tension—Epirubicin—peripheral nervous system neoplasm	0.000118	0.000283	CcSEcCtD
Zaleplon—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000118	0.000283	CcSEcCtD
Zaleplon—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000117	0.00028	CcSEcCtD
Zaleplon—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000279	CcSEcCtD
Zaleplon—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000116	0.000278	CcSEcCtD
Zaleplon—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.000277	CcSEcCtD
Zaleplon—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.000275	CcSEcCtD
Zaleplon—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000113	0.000272	CcSEcCtD
Zaleplon—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.000271	CcSEcCtD
Zaleplon—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000269	CcSEcCtD
Zaleplon—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000111	0.000268	CcSEcCtD
Zaleplon—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000111	0.000267	CcSEcCtD
Zaleplon—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000111	0.000267	CcSEcCtD
Zaleplon—Agitation—Epirubicin—peripheral nervous system neoplasm	0.00011	0.000265	CcSEcCtD
Zaleplon—Rash—Etoposide—peripheral nervous system neoplasm	0.00011	0.000265	CcSEcCtD
Zaleplon—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.00011	0.000265	CcSEcCtD
Zaleplon—Headache—Etoposide—peripheral nervous system neoplasm	0.000109	0.000263	CcSEcCtD
Zaleplon—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000263	CcSEcCtD
Zaleplon—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000262	CcSEcCtD
Zaleplon—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000261	CcSEcCtD
Zaleplon—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000108	0.00026	CcSEcCtD
Zaleplon—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000259	CcSEcCtD
Zaleplon—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000259	CcSEcCtD
Zaleplon—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000259	CcSEcCtD
Zaleplon—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000258	CcSEcCtD
Zaleplon—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000255	CcSEcCtD
Zaleplon—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000254	CcSEcCtD
Zaleplon—Nausea—Etoposide—peripheral nervous system neoplasm	0.000104	0.00025	CcSEcCtD
Zaleplon—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000249	CcSEcCtD
Zaleplon—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000248	CcSEcCtD
Zaleplon—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000247	CcSEcCtD
Zaleplon—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000102	0.000246	CcSEcCtD
Zaleplon—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000102	0.000246	CcSEcCtD
Zaleplon—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000102	0.000246	CcSEcCtD
Zaleplon—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.000245	CcSEcCtD
Zaleplon—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000102	0.000245	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000101	0.000244	CcSEcCtD
Zaleplon—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000101	0.000243	CcSEcCtD
Zaleplon—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.0001	0.000241	CcSEcCtD
Zaleplon—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.0001	0.00024	CcSEcCtD
Zaleplon—Vertigo—Doxorubicin—peripheral nervous system neoplasm	9.98e-05	0.00024	CcSEcCtD
Zaleplon—Syncope—Doxorubicin—peripheral nervous system neoplasm	9.96e-05	0.000239	CcSEcCtD
Zaleplon—Confusional state—Epirubicin—peripheral nervous system neoplasm	9.88e-05	0.000237	CcSEcCtD
Zaleplon—Palpitations—Doxorubicin—peripheral nervous system neoplasm	9.82e-05	0.000236	CcSEcCtD
Zaleplon—Oedema—Epirubicin—peripheral nervous system neoplasm	9.8e-05	0.000236	CcSEcCtD
Zaleplon—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	9.8e-05	0.000236	CcSEcCtD
Zaleplon—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	9.76e-05	0.000235	CcSEcCtD
Zaleplon—Shock—Epirubicin—peripheral nervous system neoplasm	9.64e-05	0.000232	CcSEcCtD
Zaleplon—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	9.61e-05	0.000231	CcSEcCtD
Zaleplon—Hypertension—Doxorubicin—peripheral nervous system neoplasm	9.59e-05	0.000231	CcSEcCtD
Zaleplon—Tachycardia—Epirubicin—peripheral nervous system neoplasm	9.56e-05	0.00023	CcSEcCtD
Zaleplon—Skin disorder—Epirubicin—peripheral nervous system neoplasm	9.52e-05	0.000229	CcSEcCtD
Zaleplon—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	9.47e-05	0.000228	CcSEcCtD
Zaleplon—Chest pain—Doxorubicin—peripheral nervous system neoplasm	9.46e-05	0.000227	CcSEcCtD
Zaleplon—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	9.46e-05	0.000227	CcSEcCtD
Zaleplon—Myalgia—Doxorubicin—peripheral nervous system neoplasm	9.46e-05	0.000227	CcSEcCtD
Zaleplon—Anxiety—Doxorubicin—peripheral nervous system neoplasm	9.42e-05	0.000227	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	9.39e-05	0.000226	CcSEcCtD
Zaleplon—Discomfort—Doxorubicin—peripheral nervous system neoplasm	9.34e-05	0.000225	CcSEcCtD
Zaleplon—Anorexia—Epirubicin—peripheral nervous system neoplasm	9.34e-05	0.000225	CcSEcCtD
Zaleplon—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	9.25e-05	0.000222	CcSEcCtD
Zaleplon—Hypotension—Epirubicin—peripheral nervous system neoplasm	9.15e-05	0.00022	CcSEcCtD
Zaleplon—Confusional state—Doxorubicin—peripheral nervous system neoplasm	9.14e-05	0.00022	CcSEcCtD
Zaleplon—Oedema—Doxorubicin—peripheral nervous system neoplasm	9.07e-05	0.000218	CcSEcCtD
Zaleplon—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	9.07e-05	0.000218	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	8.93e-05	0.000215	CcSEcCtD
Zaleplon—Shock—Doxorubicin—peripheral nervous system neoplasm	8.92e-05	0.000214	CcSEcCtD
Zaleplon—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	8.89e-05	0.000214	CcSEcCtD
Zaleplon—Insomnia—Epirubicin—peripheral nervous system neoplasm	8.86e-05	0.000213	CcSEcCtD
Zaleplon—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	8.85e-05	0.000213	CcSEcCtD
Zaleplon—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	8.81e-05	0.000212	CcSEcCtD
Zaleplon—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	8.8e-05	0.000211	CcSEcCtD
Zaleplon—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	8.76e-05	0.000211	CcSEcCtD
Zaleplon—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	8.73e-05	0.00021	CcSEcCtD
Zaleplon—Somnolence—Epirubicin—peripheral nervous system neoplasm	8.71e-05	0.000209	CcSEcCtD
Zaleplon—Anorexia—Doxorubicin—peripheral nervous system neoplasm	8.64e-05	0.000208	CcSEcCtD
Zaleplon—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	8.62e-05	0.000207	CcSEcCtD
Zaleplon—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	8.52e-05	0.000205	CcSEcCtD
Zaleplon—Hypotension—Doxorubicin—peripheral nervous system neoplasm	8.47e-05	0.000204	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	8.46e-05	0.000203	CcSEcCtD
Zaleplon—Pain—Epirubicin—peripheral nervous system neoplasm	8.38e-05	0.000201	CcSEcCtD
Zaleplon—Constipation—Epirubicin—peripheral nervous system neoplasm	8.38e-05	0.000201	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	8.26e-05	0.000199	CcSEcCtD
Zaleplon—Insomnia—Doxorubicin—peripheral nervous system neoplasm	8.2e-05	0.000197	CcSEcCtD
Zaleplon—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	8.14e-05	0.000196	CcSEcCtD
Zaleplon—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	8.08e-05	0.000194	CcSEcCtD
Zaleplon—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	8.07e-05	0.000194	CcSEcCtD
Zaleplon—Somnolence—Doxorubicin—peripheral nervous system neoplasm	8.06e-05	0.000194	CcSEcCtD
Zaleplon—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	8.01e-05	0.000193	CcSEcCtD
Zaleplon—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	7.98e-05	0.000192	CcSEcCtD
Zaleplon—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	7.88e-05	0.000189	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	7.83e-05	0.000188	CcSEcCtD
Zaleplon—Urticaria—Epirubicin—peripheral nervous system neoplasm	7.78e-05	0.000187	CcSEcCtD
Zaleplon—Pain—Doxorubicin—peripheral nervous system neoplasm	7.75e-05	0.000186	CcSEcCtD
Zaleplon—Constipation—Doxorubicin—peripheral nervous system neoplasm	7.75e-05	0.000186	CcSEcCtD
Zaleplon—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	7.74e-05	0.000186	CcSEcCtD
Zaleplon—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	7.74e-05	0.000186	CcSEcCtD
Zaleplon—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	7.47e-05	0.00018	CcSEcCtD
Zaleplon—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	7.41e-05	0.000178	CcSEcCtD
Zaleplon—Urticaria—Doxorubicin—peripheral nervous system neoplasm	7.2e-05	0.000173	CcSEcCtD
Zaleplon—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	7.17e-05	0.000172	CcSEcCtD
Zaleplon—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	7.17e-05	0.000172	CcSEcCtD
Zaleplon—Asthenia—Epirubicin—peripheral nervous system neoplasm	7.03e-05	0.000169	CcSEcCtD
Zaleplon—Pruritus—Epirubicin—peripheral nervous system neoplasm	6.93e-05	0.000167	CcSEcCtD
Zaleplon—Asthenia—Doxorubicin—peripheral nervous system neoplasm	6.5e-05	0.000156	CcSEcCtD
Zaleplon—Dizziness—Epirubicin—peripheral nervous system neoplasm	6.48e-05	0.000156	CcSEcCtD
Zaleplon—Pruritus—Doxorubicin—peripheral nervous system neoplasm	6.41e-05	0.000154	CcSEcCtD
Zaleplon—Rash—Epirubicin—peripheral nervous system neoplasm	6.18e-05	0.000149	CcSEcCtD
Zaleplon—Dermatitis—Epirubicin—peripheral nervous system neoplasm	6.17e-05	0.000148	CcSEcCtD
Zaleplon—Headache—Epirubicin—peripheral nervous system neoplasm	6.14e-05	0.000148	CcSEcCtD
Zaleplon—Dizziness—Doxorubicin—peripheral nervous system neoplasm	5.99e-05	0.000144	CcSEcCtD
Zaleplon—Nausea—Epirubicin—peripheral nervous system neoplasm	5.82e-05	0.00014	CcSEcCtD
Zaleplon—Rash—Doxorubicin—peripheral nervous system neoplasm	5.72e-05	0.000137	CcSEcCtD
Zaleplon—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	5.71e-05	0.000137	CcSEcCtD
Zaleplon—Headache—Doxorubicin—peripheral nervous system neoplasm	5.68e-05	0.000137	CcSEcCtD
Zaleplon—Nausea—Doxorubicin—peripheral nervous system neoplasm	5.38e-05	0.000129	CcSEcCtD
